Neuroinflammation Targeting Pyroptosis: Molecular Mechanisms and Therapeutic Perspectives in Stroke
- PMID: 38383921
- DOI: 10.1007/s12035-024-04050-6
Neuroinflammation Targeting Pyroptosis: Molecular Mechanisms and Therapeutic Perspectives in Stroke
Abstract
Pyroptosis is a recently identified type of pro-inflammatory programmed cell death (PCD) mediated by inflammasomes and nucleotide oligomerization domain-like receptors (NLs) and dependent on members of the caspase family. Pyroptosis has been widely reported to participate in the occurrence and progression of various inflammatory diseases, including stroke, a frequently lethal disease with high prevalence and many complications. To date, there have been no effectively therapeutic strategies and methods for treating stroke. Pyroptosis is thought to be closely related to the occurrence and development of stroke. Understanding inflammatory responses induced by the activation of pyroptosis would be hopeful to provide feasible approaches and strategies. Targeting on molecules in the upstream or downstream of pyroptosis pathway has shown promise in the treatment of stroke. The present review summarizes current research on the characteristics of pyroptosis, the function and pathological phenomena of pyroptosis in stroke, the molecule mechanisms related to inflammatory pathways, and the drugs and other molecules that can affect outcomes after stroke. These findings may help identify possible targets or new strategies for the diagnosis and treatment of stroke.
Keywords: Caspase; Inflammasome; Pyroptosis; Stroke.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies.J Physiol Biochem. 2021 Nov;77(4):511-529. doi: 10.1007/s13105-021-00817-w. Epub 2021 May 4. J Physiol Biochem. 2021. PMID: 33942252 Review.
-
Total paeony glycoside relieves neuroinflammation to exert antidepressant effect via the interplay between NLRP3 inflammasome, pyroptosis and autophagy.Phytomedicine. 2024 Jun;128:155519. doi: 10.1016/j.phymed.2024.155519. Epub 2024 Mar 8. Phytomedicine. 2024. PMID: 38492365
-
Targeting pyroptosis to treat ischemic stroke: From molecular pathways to treatment strategy.Int Immunopharmacol. 2024 May 30;133:112168. doi: 10.1016/j.intimp.2024.112168. Epub 2024 Apr 29. Int Immunopharmacol. 2024. PMID: 38688133 Review.
-
Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases.J Cell Physiol. 2020 Apr;235(4):3207-3221. doi: 10.1002/jcp.29268. Epub 2019 Oct 17. J Cell Physiol. 2020. PMID: 31621910 Review.
-
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.Int Immunopharmacol. 2019 Feb;67:458-464. doi: 10.1016/j.intimp.2018.12.019. Epub 2018 Dec 27. Int Immunopharmacol. 2019. PMID: 30594776 Review.
Cited by
-
Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke.Neural Regen Res. 2026 Mar 1;21(3):869-886. doi: 10.4103/NRR.NRR-D-24-01324. Epub 2025 Apr 29. Neural Regen Res. 2026. PMID: 40313116 Free PMC article.
-
Intracerebroventricular calycosin attenuates cerebral ischemia-reperfusion injury in rats via HMGB1-dependent pyroptosis inhibition.Front Pharmacol. 2025 Jun 18;16:1596087. doi: 10.3389/fphar.2025.1596087. eCollection 2025. Front Pharmacol. 2025. PMID: 40606597 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical